Midgard Science

Labs / Protein production

AP

Amogen Pharma

Hyderabad, India · amogenpharma.com

GLP · GMP

On your own

Free. Their own form.

Contact Amogen Pharma directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Amogen Pharma develops and manufactures recombinant peptide and protein biosimilars for pharmaceutical partners. It operates from Hyderabad, India, with an office in Basel, Switzerland, and serves programs from early development through commercial supply.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Microbial development services

    Genetic engineering, strain development, and microbial development in E. coli and yeast.

  • Process development

    Upstream and downstream process development from bench to commercial scale.

  • Non-GMP/CGMP manufacturing

    Flexible manufacturing from non-GMP toxicology through cGMP clinical and commercial supply.

  • Microbial manufacturing services

    Production of recombinant proteins and peptides with clinical and commercial supply capabilities.

  • Analytical development

    Comprehensive analytical method development, qualification, and transfer.

  • Microbial analytical services

    Bioassays, ELISA, microbiology, molecular biology, and related testing support.

  • Strain development

    Development of high-expressing, stable cell lines and strains.

  • Cell line development

    Proprietary platform processes for generating high-expressing, stable cell lines.

  • Quality services

    GMP batch release testing and supporting quality services across the manufacturing lifecycle.

  • API supply

    Supply of recombinant peptide APIs for long-term partnerships.

  • FDF licensing

    Licensing of finished dosage forms for partner markets.

  • Co-development

    Joint development programs for API and finished dosage form supply.

What they work on

Modalities
Small molecule, Peptide, Recombinant protein, Biosimilar
Species and models
S. cerevisiae, Saccharomyces cerevisiae, E. coli
Assays and studies
UHPLC, HPLC-UV/PDA, LC-MS, HRMS, SEC-HPLC, qPCR, bioassays, ELISA, microbiology, electrophoresis, chromatography, virology, and 2 more
Instruments and platforms
UHPLC, HPLC-UV/PDA, LC-MS, HRMS, SEC-HPLC, qPCR, Preparative Chromatography
Scale and capacity
75,000 L total fermentation capacity, 100L pre-seed bioreactor x2, 1000L seed bioreactor x4, 10,000L production bioreactor x5, 4 x 10,000L trains, 15,000L production scale, 980 kg semaglutide API capacity annually, 980 kg GLP-1 fermentation output plant, 5 x 15KL production fermenters
Therapeutic areas
GLP-1, insulin, immunology
Turnaround
NDA signed within 48 hours
What to send
Molecule information · Target markets · Development stage · Volume requirements · Analytical package review under NDA
Minimums and prices
Volume-linked pricing
Type
CRDMO
Sites
Hyderabad, India · Basel, Switzerland
Team
75+ Scientific & Manufacturing Experts
Quality
cGMP (microbial production facility) · ICH-compliant (pre-clinical report) · GMP (batch release testing and manufacturing lifecycle)
Serves
global, India, UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Canada
Founded
2020

Public records

Ownership
AMOGEN PHARMA PRIVATE LIMITED · IN GLEIF

Similar labs. GlycoNex, Inc., Alcami, Alphalyse, Bioneeds

Found in a contract services directory. Listing built from amogenpharma.com. Work here? Claim this listing.

Amogen Pharma · Midgard Science